Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment.

CD8-Positive T-Lymphocytes / metabolism Dendritic Cells / metabolism Humans Immunity, Innate Lymphocytes / metabolism Neoplasms / pathology Tumor Microenvironment Versicans / metabolism
CD40 CP: Cancer CP: Immunology cDC1 checkpoint inhibitors dendritic cells immunotherapy proteoglycans tumor matrix tumor stroma versican versikine

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
16 08 2022
Historique:
received: 08 11 2021
revised: 10 06 2022
accepted: 20 07 2022
entrez: 17 8 2022
pubmed: 18 8 2022
medline: 20 8 2022
Statut: ppublish

Résumé

Stimulatory type 1 conventional dendritic cells (cDC1s) engage in productive interactions with CD8

Identifiants

DOI: 10.1016/j.celrep.2022.111201 PMID: 35977482 PMC: PMC9402878
pubmed: 35977482
pii: S2211-1247(22)01018-X
doi: 10.1016/j.celrep.2022.111201
pmc: PMC9402878
mid: NIHMS1830639
pii:
doi:

Substances chimiques

Versicans 126968-45-4

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111201

Subventions

Organisme : NLM NIH HHS
ID : T15 LM011271
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA230275
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA252937
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA196406
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA014520
Pays : United States

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests F.A. and C.H. are listed as inventors on US patent US20170258898A1: “Versikine for inducing or potentiating an immune response.”

Références

Prostate. 2005 May 15;63(3):269-75
pubmed: 15599946
J Clin Invest. 2016 Sep 1;126(9):3176-84
pubmed: 27584731
Sci Immunol. 2020 Apr 17;5(46):
pubmed: 32303573
Front Immunol. 2021 Feb 19;11:631713
pubmed: 33679726
Immunity. 2021 Oct 12;54(10):2288-2304.e7
pubmed: 34437840
Front Immunol. 2015 May 06;6:201
pubmed: 25999946
J Immunol. 2017 Sep 1;199(5):1933-1941
pubmed: 28754680
Nat Biotechnol. 2016 Jul 12;34(7):695-7
pubmed: 27404874
Oncotarget. 2016 Mar 22;7(12):13765-81
pubmed: 26871598
Nature. 2015 Jul 9;523(7559):231-5
pubmed: 25970248
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Cancer Cell. 2017 May 8;31(5):711-723.e4
pubmed: 28486109
Nature. 2018 Feb 22;554(7693):544-548
pubmed: 29443960
Cell Rep. 2015 May 19;11(7):1018-30
pubmed: 25959818
Nat Commun. 2016 Dec 23;7:13720
pubmed: 28008905
J Immunol. 2010 Feb 1;184(3):1261-7
pubmed: 20026742
J Exp Med. 1999 Nov 15;190(10):1417-26
pubmed: 10562317
Nat Med. 2018 Aug;24(8):1178-1191
pubmed: 29942093
Immunity. 2012 Jun 29;36(6):1031-46
pubmed: 22749353
Adv Exp Med Biol. 2020;1272:55-72
pubmed: 32845502
Matrix Biol. 2014 Apr;35:34-41
pubmed: 24444773
Matrix Biol. 2014 Feb;34:1-12
pubmed: 24472738
Blood. 2014 Nov 13;124(20):3081-91
pubmed: 25100743
Blood. 2016 Aug 4;128(5):680-5
pubmed: 27259980
Front Immunol. 2020 Mar 24;11:512
pubmed: 32265939
Dev Biol. 1998 Oct 1;202(1):56-66
pubmed: 9758703
Front Immunol. 2014 May 22;5:239
pubmed: 24904587
Pharmacol Ther. 2016 Aug;164:97-104
pubmed: 27118338
J Clin Invest. 2018 Jan 2;128(1):16-25
pubmed: 29293090
Matrix Biol. 2017 Jul;60-61:38-56
pubmed: 27932299
Nat Commun. 2020 Oct 27;11(1):5415
pubmed: 33110069
Annu Rev Immunol. 2021 Apr 26;39:131-166
pubmed: 33481643
PLoS One. 2011;6(6):e20189
pubmed: 21674051
J Histochem Cytochem. 2020 Dec;68(12):871-885
pubmed: 32623942
Nature. 2009 Jan 1;457(7225):102-6
pubmed: 19122641
J Immunother. 2013 Nov-Dec;36(9):477-89
pubmed: 24145359
Nature. 2020 Aug;584(7822):624-629
pubmed: 32788723
Cell Rep. 2015 Dec 29;13(12):2851-64
pubmed: 26711349
Cell Rep. 2020 Jun 30;31(13):107818
pubmed: 32610121
Adv Immunol. 2020;148:49-91
pubmed: 33190733
J Histochem Cytochem. 2020 Nov;68(11):763-775
pubmed: 33131383
J Biol Chem. 2011 Sep 30;286(39):34298-310
pubmed: 21828051
Front Immunol. 2012 Nov 07;3:331
pubmed: 23162549
Front Immunol. 2021 Feb 03;11:621254
pubmed: 33613552
Blood. 2014 May 22;123(21):3305-15
pubmed: 24723682
Methods Mol Biol. 2016;1423:61-87
pubmed: 27142009
Mod Pathol. 2010 Dec;23(12):1605-15
pubmed: 20729814
Nat Commun. 2020 Dec 2;11(1):6171
pubmed: 33268774
Curr Opin Immunol. 2014 Apr;27:16-25
pubmed: 24531241
Elife. 2020 Jan 28;9:
pubmed: 31990272
Clin Transl Immunology. 2021 Jul 14;10(7):e1305
pubmed: 34277006
Dev Cell. 2009 Nov;17(5):687-98
pubmed: 19922873
Science. 2008 Nov 14;322(5904):1097-100
pubmed: 19008445
Nat Med. 2018 May;24(5):541-550
pubmed: 29686425
Brief Bioinform. 2007 Jan;8(1):2-5
pubmed: 16951416
Immunity. 2016 Sep 20;45(3):626-640
pubmed: 27637148
Immunity. 2018 Feb 20;48(2):396-398
pubmed: 29466761
Cell. 2017 May 4;169(4):750-765.e17
pubmed: 28475900
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nature. 2009 Nov 5;462(7269):108-12
pubmed: 19847166
Nat Commun. 2020 Nov 30;11(1):6119
pubmed: 33257678
Clin Cancer Res. 2021 Nov 15;27(22):6174-6183
pubmed: 34518312
J Clin Invest. 2013 Oct;123(10):4464-78
pubmed: 24091328
J Exp Med. 2020 Aug 3;217(8):
pubmed: 32453421
PLoS Pathog. 2021 Jan 19;17(1):e1008299
pubmed: 33465134
Int J Mol Sci. 2012;13(6):6873-82
pubmed: 22837669
Am J Respir Cell Mol Biol. 2013 Oct;49(4):503-10
pubmed: 23672262
Science. 2015 Apr 3;348(6230):74-80
pubmed: 25838376
Semin Oncol. 2015 Aug;42(4):663-71
pubmed: 26320069
Glycobiology. 2020 May 19;30(6):365-373
pubmed: 31651027
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1537-1548
pubmed: 29622560
Matrix Biol. 2020 May;87:77-93
pubmed: 31669737
Br J Cancer. 2018 Oct;119(8):950-960
pubmed: 30318514
Blood. 2021 Jan 7;137(1):61-74
pubmed: 32640012
Cancer Cell. 2014 Dec 8;26(6):938
pubmed: 28898680
PLoS Biol. 2016 Nov 17;14(11):e1002580
pubmed: 27855162
Methods Mol Biol. 2015;1229:587-604
pubmed: 25325983
Immunity. 2016 Apr 19;44(4):924-38
pubmed: 27096321
Cancer Treat Res. 2020;180:173-195
pubmed: 32215870
Cell Rep. 2021 Oct 12;37(2):109816
pubmed: 34644571
Cancer Discov. 2016 Jan;6(1):71-9
pubmed: 26493961
Nat Commun. 2013;4:2612
pubmed: 24113773
J Exp Med. 2010 Aug 2;207(8):1791-804
pubmed: 20660615
Matrix Biol. 2012 Mar;31(2):90-100
pubmed: 22155153
Matrix Biol Plus. 2021 May 14;10:100064
pubmed: 34195596
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
Matrix Biol. 2022 Mar;107:59-76
pubmed: 35176450

Auteurs

Athanasios Papadas (A)

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA; Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA.

Gauri Deb (G)

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA.

Alexander Cicala (A)

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA.

Adam Officer (A)

Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA; Division of Biomedical Informatics, Department of Medicine, University of California, San Diego (UCSD), Moores Cancer Center, La Jolla, CA, USA; Bioinformatics and Systems Biology Graduate Program, University of California, San Diego (UCSD), La Jolla, CA, USA.

Chelsea Hope (C)

Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA; Division of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA; UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

Adam Pagenkopf (A)

Division of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA; UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

Evan Flietner (E)

Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA; Division of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA; UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

Zachary T Morrow (ZT)

Division of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA; UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

Philip Emmerich (P)

Cellular and Molecular Pathology Graduate Program, University of Wisconsin-Madison, Madison, WI, USA; UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.

Joshua Wiesner (J)

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA.

Garrett Arauz (G)

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA.

Varun Bansal (V)

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA.

Karla Esbona (K)

UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.

Christian M Capitini (CM)

UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA; Division of Hematology and Oncology, Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, USA.

Kristina A Matkowskyj (KA)

UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA.

Dustin A Deming (DA)

Division of Hematology and Oncology, Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA; UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA.

Katerina Politi (K)

Department of Pathology, Yale School of Medicine, New Haven, CT, USA; Department of Medicine, Yale School of Medicine, New Haven, CT, USA; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.

Scott I Abrams (SI)

Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Olivier Harismendy (O)

Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA; Division of Biomedical Informatics, Department of Medicine, University of California, San Diego (UCSD), Moores Cancer Center, La Jolla, CA, USA.

Fotis Asimakopoulos (F)

Division of Blood and Marrow Transplantation, Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA, USA; Moores Cancer Center, University of California, San Diego (UCSD), La Jolla, CA, USA. Electronic address: fotis@health.ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Lymphocytes T CD8+ › Stromal remodeling regulates dendritic cell...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Système phagocytaire mononucléé › Cellules dendritiques › Stromal remodeling regulates dendritic cell...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Stromal remodeling regulates dendritic cell...
questionsmedicales.fr › Phénomènes du système immunitaire › Immunité › Immunité innée › Stromal remodeling regulates dendritic cell...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Stromal remodeling regulates dendritic cell...
questionsmedicales.fr › Tumeurs › Stromal remodeling regulates dendritic cell...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Microenvironnement cellulaire › Microenvironnement tumoral › Stromal remodeling regulates dendritic cell...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Scléroprotéines › Protéines de la matrice extracellulaire › Versicanes › Stromal remodeling regulates dendritic cell...